美国有几个州允许非处方销售艾弗麦丁,尽管FDA不赞同和健康风险. Several U.S. states allow over-the-counter sale of ivermectin, despite FDA disapproval and health risks.

一些美国州,包括爱达荷州、阿肯色州和田纳西州,已经通过法律,允许场外销售ivermectin,这是一种用来治疗寄生虫的药物。 Several U.S. states, including Idaho, Arkansas, and Tennessee, have passed laws allowing the over-the-counter sale of ivermectin, a drug used to treat parasitic worms. 尽管如此,FDA尚未批准其无处方使用,引发了对滥用和潜在健康风险的担忧. Despite this, the FDA has not approved it for over-the-counter use, raising concerns about misuse and potential health risks. 由于缺乏联邦指导和责任问题,药剂师不愿在没有处方的情况下出售该药物。 Pharmacists are hesitant to sell the drug without prescriptions due to lack of federal guidance and liability concerns. 超过16个州提出了类似的立法,其驱动力是未经证实的关于Ivermectin对COVID-19的有效性的指控。 Over 16 states have proposed similar legislation, driven by unproven claims about ivermectin's effectiveness against COVID-19.